) Bladder cancer is the 6th most common cancer in the developed world. More than 50,000 new cases of bladder cancer and 11,200 deaths from this cancer occur each year in the United States. Bladder carcinogenesis, like oral premalignancy, is an excellent model for chemopreventive study. Natural and synthetic retinoids have been tested as chemopreventive and chemotherapeutic agents against oral tumors, but the effects of these retinoids on bladder cancers are not well documented. The objective of the proposed study is to explore the feasibility of using natural or synthetic retinoids in the prevention and treatment Of bladder cancer and to investigate the mechanisms of retinoids in this setting. The effect of different retinoids on cell growth, differentiation, apoptosis, and expression of retinoic acid receptors (RARs) in bladder cancer cell lines and normal bladder epithelial cells in short-term cultures will be studied. The hypotheses are: a) retinoids inhibit the growth of bladder cancer cells partially through the induction of apoptosis; b) RARs, especially RARB, play a role in regulating the growth and differentiation of bladder cancer cells; and C) some receptors are down-regulated in certain bladder cancers and can be up-regulated by retinoids in vivo. The hypotheses will be examined by fulfilling the following specific aims: 1) to evaluate the effects of different retinoids on growth and differentiation in normal bladder epithelial cells and bladder cancer cells by examining morphology, cell cycle, and the expression of cytokeratins 4, 7, 8, 13, 18, and 19 using western blotting; 2) to determine the effects of different retinoids on the induction of apoptosis in bladder cancer cells by using DNA fragmentation, propidium iodide staining, and terminal deoxynucleotidyl transferase assays and the effects of combinations of RAR-selective and retinoid X receptor (RXR)-selective retinoids on growth inhibition and apoptosis to find possible additive or synergistic actions of these compounds; 3) to examine the expression of retinoid receptors and their induction by different retinoids in normal bladder epithelial cells and bladder cancer cells by using reverse-transcriptase polymerase chain reaction and western blotting to determine the relationship between receptor expression and the chemopreventive effect of different retinoids; and 4) to analyze the expression of retinoid receptors in bladder cancer specimens before and after chemoprevention with 4-(hydroxyphenyl)retinamide (4HPR) by in situ hybridization and polymerase chain reaction. The results of these studies are expected to increase our understanding of the mechanisms of action and potential usefulness of new retinoids in bladder cancer chemoprevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
5K07CA075966-04
Application #
6328987
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1998-09-30
Project End
2003-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
4
Fiscal Year
2001
Total Cost
$86,564
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Zou, Changping; Liu, Huaguang; Feugang, Jean M et al. (2010) Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer 20:617-24
Zou, Changping; Brewer, Molly; Cao, Xianyi et al. (2007) Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts. Gynecol Oncol 107:441-9
Ma, Li; Feugang, Jean Magloire; Konarski, Patricia et al. (2006) Growth inhibitory effects of quercetin on bladder cancer cell. Front Biosci 11:2275-85
Qian, Lixin; Ding, Hong; Zhou, Jianwei et al. (2006) Intravesical N-(4-hydroxyphenyl) retinamide and adriamycin induces apoptosis in bladder cancer. Front Biosci 11:2045-51
Sabichi, Anita; Keyhani, Afsaneh; Tanaka, Noriyoshi et al. (2006) Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression. J Urol 175:1133-7
Zou, Changping; Zhou, Jianwei; Qian, Linxin et al. (2006) Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells. Front Biosci 11:2007-16
Feugang, Jean Magloire; Konarski, Patricia; Zou, Daming et al. (2006) Nutritional and medicinal use of Cactus pear (Opuntia spp.) cladodes and fruits. Front Biosci 11:2574-89
Brewer, Molly; Wharton, J Taylor; Wang, Jian et al. (2005) In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer. Gynecol Oncol 98:182-92
Kirkpatrick, Nathaniel D; Zou, Changping; Brewer, Molly A et al. (2005) Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring. Photochem Photobiol 81:125-34
Zou, Da-ming; Brewer, Molly; Garcia, Francisco et al. (2005) Cactus pear: a natural product in cancer chemoprevention. Nutr J 4:25

Showing the most recent 10 out of 13 publications